Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Return on Sales (2020 - 2025)

SOPHiA GENETICS's Return on Sales history spans 6 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2025 for SOPHiA GENETICS, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for SOPH hit a ceiling of 0.01% in Q4 2024 and a floor of 0.02% in Q1 2022.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
  • Biggest five-year swings in Return on Sales: grew 4bps in 2021 and later decreased -1bps in 2022.
  • Tracing SOPH's Return on Sales over 5 years: stood at 0.02% in 2021, then surged by 47bps to 0.01% in 2022, then plummeted by -30bps to 0.01% in 2023, then surged by 44bps to 0.01% in 2024, then decreased by -17bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for SOPH at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.